COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
作者信息
Santonja C, Heras F, Núñez L, Requena L
机构信息
Department of Pathology, Fundación Jiménez Díaz, Madrid, Spain.
Department of Dermatology, Fundación Jiménez Díaz, Madrid, Spain.
出版信息
Br J Dermatol. 2020 Oct;183(4):778-780. doi: 10.1111/bjd.19338. Epub 2020 Jul 29.
Abstract
摘要
相似文献
1
COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient.
Br J Dermatol. 2020 Oct;183(4):778-780. doi: 10.1111/bjd.19338. Epub 2020 Jul 29.
2
No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain.
Br J Dermatol. 2020 Oct;183(4):784-785. doi: 10.1111/bjd.19349. Epub 2020 Jul 29.
3
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
Br J Dermatol. 2020 Oct;183(4):729-737. doi: 10.1111/bjd.19327. Epub 2020 Aug 5.
4
Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
J Am Acad Dermatol. 2020 Sep;83(3):870-875. doi: 10.1016/j.jaad.2020.05.145. Epub 2020 Jun 2.
5
Cutaneous lesions in a patient with COVID-19: are they related?
Br J Dermatol. 2020 Aug;183(2):e31. doi: 10.1111/bjd.19168. Epub 2020 Jun 15.
6
When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.
J Am Acad Dermatol. 2020 Sep;83(3):e269-e270. doi: 10.1016/j.jaad.2020.06.052. Epub 2020 Jun 19.
7
Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series.
Br J Dermatol. 2020 Oct;183(4):782-784. doi: 10.1111/bjd.19348. Epub 2020 Jul 28.
8
Chilblain-like lesions during the COVID-19 pandemic: early or late sign?
Int J Dermatol. 2020 Aug;59(8):e268-e269. doi: 10.1111/ijd.14975. Epub 2020 Jun 22.
9
Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
Int J Dermatol. 2020 Aug;59(8):1026-1027. doi: 10.1111/ijd.14993. Epub 2020 Jun 4.
10
New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
J Am Acad Dermatol. 2020 Oct;83(4):1219-1222. doi: 10.1016/j.jaad.2020.06.1018. Epub 2020 Jul 3.
引用本文的文献
1
Type I Interferons in SARS-CoV-2 Cutaneous Infection: Is There a Role in Antiviral Defense?
Int J Mol Sci. 2025 Jun 24;26(13):6049. doi: 10.3390/ijms26136049.
2
Onset of leukocytoclastic vasculitis following covid-19 vaccination: case based comprehensive review.
Rheumatol Int. 2024 Nov;44(11):2621-2635. doi: 10.1007/s00296-024-05718-x. Epub 2024 Sep 16.
3
Rare and common manifestations of COVID-19 in children.
JEADV Clin Pract. 2022 Mar;1(1):21-30. doi: 10.1002/jvc2.10. Epub 2022 Feb 18.
4
Engineering Materials and Devices for the Prevention, Diagnosis, and Treatment of COVID-19 and Infectious Diseases.
Nanomaterials (Basel). 2023 Aug 30;13(17):2455. doi: 10.3390/nano13172455.
5
Pemphigus Vulgaris Possibly Associated with COVID-19 Infection.
Cureus. 2023 Jan 17;15(1):e33897. doi: 10.7759/cureus.33897. eCollection 2023 Jan.
6
Expert considerations and consensus for using dogs to detect human SARS-CoV-2-infections.
Front Med (Lausanne). 2022 Dec 8;9:1015620. doi: 10.3389/fmed.2022.1015620. eCollection 2022.
7
Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination.
Front Med (Lausanne). 2022 Dec 9;9:1013846. doi: 10.3389/fmed.2022.1013846. eCollection 2022.
8
Clinicopathologic features among different viral epidemic outbreaks involving the skin.
Clin Dermatol. 2022 Sep-Oct;40(5):573-585. doi: 10.1016/j.clindermatol.2021.06.003. Epub 2021 Jun 17.
9
Chilblains observed during the COVID-19 pandemic cannot be distinguished from classic, cold-related chilblains.
Eur J Dermatol. 2022 May 1;32(3):377-383. doi: 10.1684/ejd.2022.4260.
10
The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.
Dermatopathology (Basel). 2022 Jun 29;9(3):212-243. doi: 10.3390/dermatopathology9030027.
本文引用的文献
1
Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea.
J Med Virol. 2021 Jan;93(1):61-63. doi: 10.1002/jmv.26119. Epub 2020 Jun 24.
2
Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue.
Br J Dermatol. 2020 Sep;183(3):431-442. doi: 10.1111/bjd.19264. Epub 2020 Jul 5.
3
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
4
Endothelial cell infection and endotheliitis in COVID-19.
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
5
Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
J Med Virol. 2020 Jul;92(7):699-702. doi: 10.1002/jmv.25915.
6
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.
Transl Res. 2020 Jun;220:1-13. doi: 10.1016/j.trsl.2020.04.007. Epub 2020 Apr 15.
7
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways.
J Pathol. 2004 Jun;203(2):622-30. doi: 10.1002/path.1560.
8
Hepatitis C virus replicates in sweat glands and is released into sweat in patients with chronic hepatitis C.
J Med Virol. 2002 Dec;68(4):529-36. doi: 10.1002/jmv.10238.
Zotero 插件